About this program

NIH is the largest funder of biomedical research globally. Their SBIR/STTR program invests $1.2B/year in health and life science startups. Phase I: $275K. Phase II: $1.5M. Phase IIB: $3M. Perfect for healthtech, biotech, medtech, digital health, and therapeutic startups. This is Phase I (proof of concept / feasibility study).

Focus Areas

Stages

PRE SEED

Industries

HEALTHTECHBIOTECH

Target Regions

United States

Perks & Benefits

Up to $275,000 non-dilutive funding

No equity given up — 100% equity-free

Credibility signal for future fundraising

Deadline not on file

NIH SBIR/STTR — Phase I

About this program

Focus Areas

Stages

Industries

Target Regions

Perks & Benefits

Funding Details

Program Stats

Data Quality